Sibnayal Eiropas Savienība - rumāņu - EMA (European Medicines Agency)

sibnayal

advicenne s.a. - potassium citrate monohydrated, potassium hydrogen carbonate - acidosis, renal tubular - mineral supplements - sibnayal is indicated for the treatment of distal renal tubular acidosis (drta) in adults, adolescents and children aged one year and older.

Drovelis Eiropas Savienība - rumāņu - EMA (European Medicines Agency)

drovelis

gedeon richter plc. - drospirenone, estetrol monohydrate - contraceptives, oral - hormoni sexuali și modulatori ai sistemului genital, - oral contraceptive.

Lydisilka Eiropas Savienība - rumāņu - EMA (European Medicines Agency)

lydisilka

estetra sprl - estetrol monohydrate, drospirenone - contraceptives, oral - hormoni sexuali și modulatori ai sistemului genital, - contracepție orală. the decision to prescribe lydisilka should take into consideration the individual woman’s current risk factors, particularly those for venous thromboembolism (vte), and how the risk of vte with lydisilka compares with other combined hormonal contraceptives (chcs) (see sections 4. 3 and 4.

Tepmetko Eiropas Savienība - rumāņu - EMA (European Medicines Agency)

tepmetko

merck europe b.v. - tepotinib hydrochloride monohydrate - carcinom, pulmonar non-celulă mică - agenți antineoplazici - tepmetko as monotherapy is indicated for the treatment of adult patients with advanced non-small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal-epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum-based chemotherapy.

Tabrecta Eiropas Savienība - rumāņu - EMA (European Medicines Agency)

tabrecta

novartis europharm limited  - capmatinib dihydrochloride monohydrate - carcinom, pulmonar non-celulă mică - agenți antineoplazici - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.

Sitagliptin / Metformin hydrochloride Accord Eiropas Savienība - rumāņu - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetul zaharat, tip 2 - medicamente utilizate în diabet - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. , terapie triplă) ca adjuvant la dietă și exercițiu fizic, la pacienți controlați inadecvat cu doza maximă tolerată de metformin și o sulfoniluree. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Akeega Eiropas Savienība - rumāņu - EMA (European Medicines Agency)

akeega

janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - neoplasmele prostatice, rezistent la castrare - agenți antineoplazici - treatment of adult patients with prostate cancer.

Adrovance Eiropas Savienība - rumāņu - EMA (European Medicines Agency)

adrovance

n.v. organon - colecalciferol, alendronic acid (as sodium trihydrate) - osteoporoza, postmenopauză - medicamente pentru tratamentul bolilor osoase - tratamentul osteoporozei postmenopauzale la pacienții cu risc de insuficiență de vitamina d. adrovance reduce riscul fracturilor vertebrale și de șold.

PegIntron pulbere si solvent pentru solutie injectabila 100 mcg/0,5 ml Moldova - rumāņu - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

pegintron pulbere si solvent pentru solutie injectabila 100 mcg/0,5 ml

merck sharp&dohme limited - peginterferon alfa-2b - pulbere si solvent pentru solutie injectabila - 100 mcg/0,5 ml

PegIntron pulbere si solvent pentru solutie injectabila 120 mcg/0,5 ml Moldova - rumāņu - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

pegintron pulbere si solvent pentru solutie injectabila 120 mcg/0,5 ml

merck sharp&dohme limited - peginterferon alfa-2b - pulbere si solvent pentru solutie injectabila - 120 mcg/0,5 ml